Gene · 1806
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Assessing the Occurrence and Influence of Cancer Chemotherapy-Related Pharmacogenetic Alleles in the Chilean Population. | Pharmaceutics | 2024 | 38675222 | PubTator, text mining | PubMed |
| Contradiction in Star-Allele Nomenclature of Pharmacogenes between Common Haplotypes and Rare Variants. | Genes (Basel) | 2024 | 38674455 | PubTator, text mining | PubMed |
| [Elesclomol-Cu Induces Cuproptosis in Human Acute Myeloid Leukemia Cells]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2024 | 38660841 | PubTator, text mining | PubMed |
| Exploring the impact of MiR-92a-3p on FOLFOX chemoresistance biomarker genes in colon cancer cell lines. | Front Pharmacol | 2024 | 38659583 | PubTator, text mining | PubMed |
| Response to "DPYD genotyping panels: Impact of population diversity". | Clin Transl Sci | 2024 | 38637962 | PubTator, text mining | PubMed |
| DPYD genotyping panels: Impact of population diversity. | Clin Transl Sci | 2024 | 38634417 | PubTator, text mining | PubMed |
| [Astragali Radix-Curcumae Rhizoma inhibits colon cancer progression and enhances 5-FU efficacy by regulating hypoxia-inducible factors and tumor stem cells]. | Zhongguo Zhong Yao Za Zhi | 2024 | 38621911 | PubTator, text mining | PubMed |
| Design and Implementation of an Opt-Out, End-to-End, Preemptive DPYD Testing Program for Patients Planned for a Systemic Fluoropyrimidine. | JCO Oncol Pract | 2024 | 38608224 | PubTator, text mining | PubMed |
| Genomic medicine for the 21st century. | Ann R Coll Surg Engl | 2024 | 38555870 | PubTator, text mining | PubMed |
| A novel large intragenic DPYD deletion causing dihydropyrimidine dehydrogenase deficiency: a case report. | BMC Med Genomics | 2024 | 38528593 | PubTator, text mining | PubMed |
| Complete DPYD genotyping combined with dihydropyrimidine dehydrogenase phenotyping to prevent fluoropyrimidine toxicity: A retrospective study. | Cancer Med | 2024 | 38523525 | PubTator, text mining | PubMed |
| Fluoropyrimidine Toxicity: the Hidden Secrets of DPYD. | Curr Drug Metab | 2024 | 38504562 | PubTator, text mining | PubMed |
| Diversity of oncopharmacogenetic profile within Spanish population. | Pharmacogenet Genomics | 2024 | 38488402 | PubTator, text mining | PubMed |
| Citizen science data on urban forageable plants: a case study in Brazil. | GigaByte | 2024 | 38434929 | PubTator, text mining | PubMed |
| Effect of Liver Dysfunction on S-1 Therapy Induced Adverse Effects: A Retrospective Cohort Study. | In Vivo | 2024 | 38418130 | PubTator, text mining | PubMed |
| CIAO1 and MMS19 deficiency: A lethal neurodegenerative phenotype caused by cytosolic Fe-S cluster protein assembly disorders. | Genet Med | 2024 | 38411040 | PubTator, text mining | PubMed |
| Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma. | Int J Mol Sci | 2024 | 38396873 | PubTator, text mining | PubMed |
| MIR27A rs895819 TC genotype increases risk of fluoropyrimidine-induced severe toxicity independently of DPYD variations. | Pharmacogenomics | 2024 | 38353109 | PubTator, text mining | PubMed |
| Model-Based Prediction of Irinotecan-Induced Grade 4 Neutropenia in Cancer Patients: Influence of Incorporating Germline Genetic Factors in the Model. | Clin Pharmacol Ther | 2024 | 38344867 | PubTator, text mining | PubMed |
| Primary vulvar adenocarcinoma of intestinal type: Report of two cases showing molecular similarity with colorectal adenocarcinoma. | Pathol Res Pract | 2024 | 38340583 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1806/papers?page=15